Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1973-6-11
|
pubmed:language |
nor
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0029-2001
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
93
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
395-8
|
pubmed:dateRevised |
2008-7-16
|
pubmed:meshHeading |
pubmed-meshheading:4698026-Administration, Oral,
pubmed-meshheading:4698026-Drug Interactions,
pubmed-meshheading:4698026-Epilepsy,
pubmed-meshheading:4698026-Humans,
pubmed-meshheading:4698026-Isoniazid,
pubmed-meshheading:4698026-Phenytoin,
pubmed-meshheading:4698026-Protein Binding,
pubmed-meshheading:4698026-Time Factors
|
pubmed:year |
1973
|
pubmed:articleTitle |
[Phenytoin--blood levels and clinical aspects].
|
pubmed:publicationType |
Journal Article
|